The impact of the COVID-19 pandemic on hospitalizations and plasmapheresis therapy in multiple sclerosis and neuromyelitis optica spectrum disorder: a nationwide analysis from Germany

BACKGROUND: Many countries worldwide reported side effects of the coronavirus disease 2019 (COVID-19) pandemic that have influenced the care of patients with other diseases in both acute and elective settings. Patients with multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) r...

Descripción completa

Detalles Bibliográficos
Autores principales: Richter, Daniel, Faissner, Simon, Bartig, Dirk, Tönges, Lars, Hellwig, Kerstin, Ayzenberg, Ilya, Krogias, Christos, Gold, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267031/
https://www.ncbi.nlm.nih.gov/pubmed/34285719
http://dx.doi.org/10.1177/17562864211030656

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8267031/
https://www.ncbi.nlm.nih.gov/pubmed/34285719
http://dx.doi.org/10.1177/17562864211030656

Ejemplares similares